News

CannaLean – Revolutionizing the Future of Cannabis (Mar 2019):

Stero Biotechs to Commence Phase 2 Clinical Trial of ST-AH-01 Cannabidiol Formulation for Ground Breaking Maintenance Therapy and Steroid Reduction in Patients With Autoimmune Hepatitis (Feb 2019 – www.prnewswire.com)

How Stero is leading the way in using CBD in place of Steroids (Jan 2019)

CannaLean Develops New Cannabidiol & Chitosan Formulation to Safely Lower Cholesterol and Triglyceride Levels; A Stain Alternative With Fewer Risks (Nov 2018)

STERO Biotechs Secures Patent of CBD as Steroid Sparing Treatment, Breakthrough Will
Potentially Allow Significant Dosage Reduction (Aug 2018)

Kalytera buys Israeli cannabis co Talent Biotech (Feb 2017)